Benzylamine Dolutegravir is a synthetic byproduct arising during the multi-step synthesis of Dolutegravir, characterized by the incorporation of a benzylamine moiety into the integrase inhibitor scaffold. This impurity features a substituted pyrimidine core linked to a benzylamine group via an amidic linkage, with a terminal carboxamide functionality. Its structural similarity to the parent compound facilitates competitive inhibition during chromatographic resolution. This compound serves as a critical HPLC reference standard for quantifying process-related impurities in Dolutegravir drug substance.
On Request